1. Yin, Shenmin, Goodrich, David W. . Combination gene therapy with p53 and Thoc1/p84 is more effective than either single agent in an animal model of human pancreatic adenocarcinoma. In International journal of oncology, 28, 781-5. doi:. https://pubmed.ncbi.nlm.nih.gov/16465385/
2. Wang, Xiaoling, Chinnam, Meenalakshmi, Wang, Jianmin, Moens, Peter, Goodrich, David W. 2009. Thoc1 deficiency compromises gene expression necessary for normal testis development in the mouse. In Molecular and cellular biology, 29, 2794-803. doi:10.1128/MCB.01633-08. https://pubmed.ncbi.nlm.nih.gov/19307311/
3. Wang, Xiaoling, Li, Yanping, Zhang, Xiaojing, Goodrich, David W. . An allelic series for studying the mouse Thoc1 gene. In Genesis (New York, N.Y. : 2000), 45, 32-7. doi:. https://pubmed.ncbi.nlm.nih.gov/17211872/
4. Chinnam, Meenalakshmi, Wang, Yanqing, Zhang, Xiaojing, Mohler, James L, Goodrich, David W. 2014. The Thoc1 ribonucleoprotein and prostate cancer progression. In Journal of the National Cancer Institute, 106, . doi:10.1093/jnci/dju306. https://pubmed.ncbi.nlm.nih.gov/25296641/
5. Pitzonka, Laura, Ullas, Sumana, Chinnam, Meenalakshmi, Evans, Sharon, Goodrich, David W. 2014. The Thoc1 encoded ribonucleoprotein is required for myeloid progenitor cell homeostasis in the adult mouse. In PloS one, 9, e97628. doi:10.1371/journal.pone.0097628. https://pubmed.ncbi.nlm.nih.gov/24830368/
6. Zhang, Luping, Gao, Yu, Zhang, Ru, Wu, Hao, Liu, Dong. 2020. THOC1 deficiency leads to late-onset nonsyndromic hearing loss through p53-mediated hair cell apoptosis. In PLoS genetics, 16, e1008953. doi:10.1371/journal.pgen.1008953. https://pubmed.ncbi.nlm.nih.gov/32776944/
7. Wang, Xiaoling, Chang, Yanjie, Li, Yanping, Zhang, Xiaojing, Goodrich, David W. . Thoc1/Hpr1/p84 is essential for early embryonic development in the mouse. In Molecular and cellular biology, 26, 4362-7. doi:. https://pubmed.ncbi.nlm.nih.gov/16705185/
8. Liu, Chenchen, Yue, Ben, Yuan, Chenwei, Yu, Yang, Yan, Dongwang. 2015. Elevated expression of Thoc1 is associated with aggressive phenotype and poor prognosis in colorectal cancer. In Biochemical and biophysical research communications, 468, 53-8. doi:10.1016/j.bbrc.2015.10.166. https://pubmed.ncbi.nlm.nih.gov/26545775/